Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J7CH
|
|||
| Former ID |
DIB010141
|
|||
| Drug Name |
QGE-031
|
|||
| Indication | Chronic idiopathic urticaria [ICD-11: EB00.1; ICD-10: L50.1; ICD-9: 708] | Phase 3 | [1] | |
| Thyroid cancer [ICD-11: 2D10; ICD-10: C73; ICD-9: 193] | Phase 2 | [2] | ||
| Company |
Novartis pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02336425) Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.